JP Morgan Maintains Overweight on Agilent Technologies, Raises Price Target to $190
JP Morgan analyst Casey Woodring maintains Agilent Technologies (NYSE:A) with a Overweight and raises the price target from $180 to $190.
Read original at benzingaStocks · News reference
Agilent Technologies shares are trading higher after the company announced it has received EU certification for PD-L1 IHC 22C3 pharmDx, in identifying epithelial ovarian, fallopian tube, or primary peritoneal carcinoma.
102.76 +0.14 [+0.14%]
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 23, 2026, 2:34 PM
- Checked
- Jul 23, 2026, 2:34 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
TD Cowen Maintains Buy on Agilent Technologies, Raises Price Target to $180
TD Cowen analyst Dan Brennan maintains Agilent Technologies (NYSE:A) with a Buy and raises the price target from $155 to $180.
Read original at benzingaLaboratory Informatics Market to Grow from USD 4.08 Billion in 2025 to USD 6.69 Billion by 2035, at a CAGR of 5.06% - SNS Insider
The global laboratory informatics market is projected to grow at a CAGR of 5.06% from 2025 to 2035, driven by increased data processing demands, regulatory compliance requirements, and adoption of cloud-native solutions and AI-driven analytics. North America leads with 42.55% market share, while Asia-Pacific is the fastest-growing region. Services and LIMS products dominate, with cloud delivery and electronic lab notebooks showing the strongest growth rates.
Read original at globenewswire-incBernstein Maintains Outperform on Agilent Technologies, Raises Price Target to $180
Bernstein analyst Eve Burstein maintains Agilent Technologies (NYSE:A) with a Outperform and raises the price target from $155 to $180.
Read original at benzinga